Colgate-Palmolive Company $CL Stock Holdings Increased by Lbp Am Sa

Lbp Am Sa lifted its holdings in Colgate-Palmolive Company (NYSE:CL) by 7.7% in the 3rd quarter, HoldingsChannel reports. The firm owned 228,323 shares of the company’s stock after purchasing an additional 16,240 shares during the quarter. Lbp Am Sa’s holdings in Colgate-Palmolive were worth $18,252,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 1.2% during the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after buying an additional 993,432 shares during the period. Norges Bank acquired a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $960,390,000. Invesco Ltd. raised its holdings in Colgate-Palmolive by 9.1% during the second quarter. Invesco Ltd. now owns 7,489,050 shares of the company’s stock worth $680,755,000 after purchasing an additional 621,841 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Colgate-Palmolive by 42.9% during the second quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock worth $556,663,000 after purchasing an additional 1,839,853 shares in the last quarter. Finally, Schroder Investment Management Group lifted its position in Colgate-Palmolive by 242.3% in the second quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock worth $483,962,000 after purchasing an additional 3,768,784 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 1.0%

NYSE:CL opened at $86.67 on Monday. The stock has a market cap of $69.86 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 5.85 and a beta of 0.30. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. The stock’s 50-day moving average is $80.07 and its two-hundred day moving average is $81.43.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. During the same period last year, the company posted $0.91 earnings per share. The firm’s quarterly revenue was up 1.9% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.

Analysts Set New Price Targets

A number of research firms have recently commented on CL. Barclays set a $83.00 price objective on Colgate-Palmolive in a report on Friday, January 16th. The Goldman Sachs Group cut their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, October 2nd. UBS Group raised their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research report on Wednesday, January 14th. Citigroup dropped their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a report on Monday, November 3rd. Finally, Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Eleven research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $89.44.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.